Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(14%)

Phase Distribution

Ph not_applicable
5
71%
Ph early_phase_1
1
14%
Ph phase_2
1
14%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(1)
Terminated(2)
Other(3)

Detailed Status

unknown3
Withdrawn1
Terminated1
Completed1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (14.3%)
Phase 21 (14.3%)
N/A5 (71.4%)

Trials by Status

withdrawn114%
terminated114%
completed114%
not_yet_recruiting114%
unknown343%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7